by Jordana Choucair | Apr 27, 2022 | Life Sciences
Pfizer and BioNTech requested Food and Drug Administration (FDA) authorization of a booster dose of its COVID-19 vaccine for children 5 through 11. The companies have said that a third vaccine dose raised Omicron-fighting antibodies by 36 times in this age group....
by Jordana Choucair | Apr 27, 2022 | M&A
A new report from KPMG found that the health care sector completed 34 percent fewer deals in the first quarter of 2022 compared to the fourth quarter of 2021. The firm said that deal activity fell because of business disruptions from the COVID-19 omicron surge early...
by Jordana Choucair | Apr 27, 2022 | Payers
The Kaiser Family Foundation released a new interactive providing key facts and trends about spending on Medicare. In 2020, Medicare benefit payments totaled $769 billion, representing 12 percent of the federal budget and 20 percent of national health care spending....
by Jordana Choucair | Apr 27, 2022 | Public Health/Prevention
The Centers for Disease Control and Prevention (CDC) released new data indicating that nearly 60 percent of U.S. adults and 75 percent of children under the age of 18 have antibodies that indicate prior COVID-19 coronavirus infection. According to the study, as of...
by Jordana Choucair | Apr 27, 2022 | Public Health/Prevention
The U.S. Preventive Services Task Force released new guidance stating that people over the age of 60 should not start taking daily, low-dose aspirin to prevent cardiovascular events like heart attacks or strokes. Low-dose aspirin had been a popular prevention measure,...
by Jordana Choucair | Apr 26, 2022 | D.C. News
The White House unveiled new steps aimed at making highly effective COVID-19 treatment pills from Pfizer more widely available. The administration said that it will add 10,000 sites where the Paxlovid pills are available – bringing the total number of sites to 30,000...
Recent Comments